Pipex to start Phase II fibromyalgia trial
This Phase II clinical trial is designed as a double-blind, placebo controlled trial that would evaluate safety and efficacy of oral flupirtine versus placebo in fibromyalgia patients. The
BeOne Medicines is set to invest $300m in expanding its manufacturing and research operations at the Princeton West Innovation Campus in Hopewell, New Jersey, US.